Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-held and emerging growth companies in the Health Sciences, Biotech and Technology industries.
Ramko has extensive experience serving large, publicly-held companies as well as newly formed start-ups and venture-backed enterprises. Richard has 15 years of experience, including 13 years in public accounting and 2 years in executive level financial positions in private industry and is a certified public accountant in Florida and Tennessee. Some of his current clients include Andrx Corporation, Nabi Biopharmaceuticals, Stiefel Laboratories and SFBC International.
Well, I think going back to 2000 and such when there were a lot of companies that went public that probably never should have gone public, I think what Sarbanes-Oxley has done has made companies and investors take a look and say what will we get out by going public? Do we really need to go public; ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
